Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors.

Finally, the possibility of the immunomodulatory therapies themselves resulting in some of the findings, such as the highly significant association with drug metabolism pathways in the second cohort, must be considered.

also in 132,142 other papers